source
- Sanofi R&D chief urges Western pharma to factor China’s growing innovation into pipelinesSanofi’s newly appointed head of research and development said on Wednesday that Western pharmaceutical companies can no longer overlook China’s rapid progress in biopharma innovation. He noted th…
- Gilead invests up to $1.87 B in Vir Biotechnology for three T-cell engagersGilead Sciences announced a licensing agreement with Vir Biotechnology that includes an equity investment and potential milestone payments totalling up to $1.87 billion. The upfront component is $…